Percutaneous valve procedures: present and future.
Percutaneous mitral commissurotomy and aortic valvuloplasty have been being performed since the mid-1980s. Balloon commissurotomy has been used in thousands of cases worldwide and it provides good short- and long-term results in a wide range of patients. It has virtually replaced surgical commissurotomy in the treatment of mitral stenosis. In contrast, percutaneous aortic valvuloplasty is almost abandoned worldwide due to its lack of efficacy and the risks involved. The new techniques of percutaneous valve intervention: aortic valve replacement and mitral valve repair are at an early stage: the first in-man applications of these fledgling techniques started in 2002. Preliminary series show that they are feasible; however, they need to be further evaluated in comparison with contemporary treatment to assess accurately how efficient they are and the risks involved. Currently potential applications concern high-risk patients, however, in the future, after thorough evaluation, this may be extended to others. Thus, percutaneous interventions already play an important role in treatment of valvular heart disease, a role that seems set for future expansion.
Tawn
Zamer
Z
Bichat Hospital, Paris, France.
Himbert
Dominique
D
Brochet
Eric
E
Messika-Zeitoun
David
D
Iung
Bernard
B
Vahanian
Alec
A
D000792:Angiography; D000818:Animals; D001024:Aortic Valve Stenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D002404:Catheterization / Q000592:standards / Q000639:trends*; D004195:Disease Models, Animal; D005260:Female; D005544:Forecasting; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008946:Mitral Valve Stenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D011379:Prognosis; D015642:Radiology, Interventional / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D015607:Stents; D016896:Treatment Outcome